Acute ischemic stroke(AIS)is one of the serious diseases endangering human health worldwide;it usually leads to serious handicap with a high risk of recurrence and death.Despite the global burden of stroke,great advances are still being made.Since the publication of the 2013 guidelines for the ...
Chinese guidelines for the endovascular treatment of acute ischemic stroke 2018 are based on the current available evidence and the realities of clinical practice in China. These guidelines supersede the 2015 guidelines. The writing members of the guidelines were appointed by the Chinese Stroke Society...
The initial therapeutic approach to acute ischemic stroke consists of thrombolytic therapy and early initiation of supportive care, usually commenced prior to the determination of the underlying stroke etiology. Varying stroke mechanisms may call for specific, etiology-based treatment. The majority of str...
OBJECTIVE: To review the most recent, high-quality evidence for acute stroke treatment. METHODS: Systematic review of relevant published studies focused in several aspects of acute ischemic stroke management, from neuroprotection to thrombolysis. CONCLUSIONS: After the publication of NINDS rt-PA study,...
Do not administer Activase to treat acute ischemic stroke in the following situations in which the risk of bleeding is greater than the potential benefit: current intracranial hemorrhage (ICH); subarachnoid hemorrhage; active internal bleeding; recent (within 3 months) intracranial or intraspinal surgery...
Acute Ischemic Stroke Management: Administration of Thrombolytics, Neuroprotectants, and General Principles of Medical Management The pathophysiology of acute ischemic stroke involves occlusion of a cerebral artery; therefore, cerebral reperfusion is the primary goal of acute treatmen... AM Khaja - 《Neur...
PURPOSE: The aim of this guideline is to provide a focused update of the current recommendations for the endovascular treatment of acute ischemic stroke. When there is overlap, the recommendations made here supersede those of previous guidelines. METHODS: This focused update analyzes results from 8...
Commentary Treatmentofacuteischemicstrokeinpatientswith cerebralmicrobleeds:adecisionanalysis J.BENBASSAT 1 ,R.BAUMAL 2 andY.HERISHANU 3 Fromthe 1 Myers-JDC-BrookdaleInstitute,theSmoklerCenterforHealthPolicyResearch,Jerusalem, Israel, 2 DepartmentofLaboratoryMedicineandPathobiology,TorontoHospitalforSickChildren...
This randomized clinical trial investigates if sublingual edaravone dexborneol improves functional outcome in patients with acute ischemic stroke.
Two main causes of stroke are clotting in an artery that supplies blood to the brain (ischemic stroke), and bleeding into the brain tissue, often from a defect in a blood vessel in the brain (hemorrhagicstroke); mini-strokes (TIAs) are usually temporary ischemic strokes that quickly resolve...